Ion Exchange India Ltd. saw its shares surge by nearly 13% in Friday's trade, reaching a day high of Rs 454. The significant uptick followed the company's announcement of a substantial international order valued at $52.83 million, approximately Rs 503 crore, from Hyundai Engineering & Construction Co Ltd.
Major International Contract Fuels Growth
The newly awarded contract involves the supply of critical filtration units destined for the Middle East region. Ion Exchange India expects to execute this project over an 18-month period, a strategic move poised to bolster its presence in key international markets. This order underscores the company's expertise in water treatment and filtration solutions on a global scale.
Financial Performance Overview
For the March quarter (Q4 FY26), Ion Exchange India reported a consolidated operating income of Rs 863.3 crore, marking an approximate 3% year-on-year increase. The quarter's EBITDA stood at Rs 19.9 crore, with an EBITDA margin of 2.31%, and net profit reached Rs 24.3 crore, translating to a PAT margin of 2.81%.
Looking at the full financial year 2025-26 (FY26), the company posted an operating income of Rs 2,914.8 crore, a roughly 7% increase year-on-year. However, EBITDA for the year saw a decline of 29% year-on-year, settling at Rs 210.2 crore with a margin of 7.21%. Net profit for FY26 was Rs 143.2 crore, achieving a PAT margin of 4.91%.
Strategic Developments and Outlook
During the recent earnings call, Group Chief Financial Officer Vasant Naik addressed challenges and strategic initiatives. He noted that planned dispatches for high-value engineering contracts to GCC geographies in Q4 FY26 were impacted by disruptions from the West Asia crisis. However, customer clearances have since been secured, allowing execution to proceed post-quarter end.
Naik also highlighted significant project milestones, including the successful commissioning of the raw water treatment plant for the IOCL Panipat Refinery project, which represents India's largest industrial water treatment package. Furthermore, Ion Exchange India has forged a technology transfer and manufacturing collaboration with MANN+HUMMEL, a global leader in filtration technology. This partnership aims to manufacture ultra-filtration membranes and transfer membrane bioreactor technology to India, significantly strengthening the company's membrane portfolio and technological offerings.